Signature »

Candel Therapeutics shares owned by Signature

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Signature from 13F filings

Historical chart of Signature investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by Signature consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by Signature

Quarter filed Position value Share count Share price at filing
2025-03-31 $219 39 5.64

More positions owned by Signature

Ishares Tr Rus 1000 Grw Etf (IWF)
Ishares Tr Core S&p Us Vlu (IUSV)
Vanguard Specialized Funds Div App Etf (VIG)
Vanguard Malvern Fds Core Bd Etf (VCRB)
J P Morgan Exchange Traded F Us Qualty Fctr (JQUA)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr National Mun Etf (MUB)
Vanguard Index Fds Large Cap Etf (VV)
Microsoft Corporation (MSFT)
Vanguard Index Fds Growth Etf (VUG)

View all positions for Signature

Top funds holding Candel Therapeutics

FMR
Acorn Capital Advisors
BlackRock
Vanguard Group
Portolan Capital Management
Geode Capital Management
Halter Ferguson Financial
State Street Corporation
Citadel Advisors
Sands Capital Ventures
Susquehanna International
Northern Trust
Nuveen
Tanager Wealth Management
Wellington Management Company

View all funds holding Candel Therapeutics